Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Addressing antibiotic resistance.

Kalpana Gupta1

  • 1Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle 98195, USA.

The American Journal of Medicine
|July 13, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An education with audit and targeted feedback intervention to de-implement preoperative surgical urine cultures: a multi-center quasi-experimental study.

Infection control and hospital epidemiology·2026
Same author

Activity in barrel cortex related to tactile delay eyeblink conditioning.

Cerebral cortex (New York, N.Y. : 1991)·2026
Same author

Renovating the Barnes maze for mouse models of dementia with STARR FIELD: A 4-day protocol for learning rate, retention, and cognitive flexibility.

Methods (San Diego, Calif.)·2026
Same author

State-of-the-Art Review: Diagnosis and Management of Acute and Chronic Bacterial Prostatitis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Introduction and Methods.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Timing of Intravenous to Oral Antibiotics Transition for Complicated UTI.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025

Rising antibiotic resistance to trimethoprim-sulfamethoxazole (TMP-SMX) impacts urinary tract infection (UTI) treatment. For uncomplicated UTIs, TMP-SMX is less effective where resistance exceeds 20%, necessitating alternative empiric therapies.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Urology

Background:

  • Uncomplicated urinary tract infections (UTIs) traditionally treated with trimethoprim-sulfamethoxazole (TMP-SMX) due to predictable bacterial susceptibility.
  • Increasing antibiotic resistance, particularly to TMP-SMX (18-22%) and amoxicillin (nearly 33%), now affects community-acquired UTIs.
  • Resistance to nitrofurantoin and fluoroquinolones remains low (approx. 2%).

Purpose of the Study:

  • To evaluate the impact of rising antibiotic resistance on the management of uncomplicated community-acquired UTIs.
  • To determine the threshold for TMP-SMX resistance above which its use as a first-line empiric therapy is inappropriate.
  • To identify alternative treatment strategies for uncomplicated UTIs in regions with high TMP-SMX resistance.

Main Methods:

Related Experiment Videos

  • Review of current literature and resistance prevalence data for common UTI pathogens.
  • Analysis of the relationship between TMP-SMX resistance rates and treatment outcomes.
  • Assessment of alternative antibiotic agents based on efficacy and resistance patterns.

Main Results:

  • TMP-SMX resistance in some US regions approaches 22%, challenging its standard use for uncomplicated cystitis.
  • High TMP-SMX resistance is linked to poorer clinical and bacteriologic outcomes.
  • Nitrofurantoin and fluoroquinolones demonstrate sustained low resistance rates, indicating potential alternatives.

Conclusions:

  • The prevalence of TMP-SMX resistance necessitates a shift in empiric therapy guidelines for uncomplicated UTIs.
  • TMP-SMX should only be considered first-line where resistance is below 10-20%.
  • Alternative antibiotics like nitrofurantoin and fluoroquinolones are recommended for empiric treatment in high-resistance areas.